Treatment enhances anti-leukemia effect of bone marrow transplant, reduces recurrence, study finds – Newswise

Newswise — ANN ARBOR, Michigan — Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
…

Click here to view the original article.